Olatec Therapeutics
PrivateLast Round
Series B
Nov 9, 2025
Total Funding Raised
$40M
Company Overview
Olatec Therapeutics is a biopharmaceutical company that develops oral small-molecule therapeutics targeting the NLRP3 inflammasome and Interleukin-1 pathways to treat inflammatory and immune-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Olatec Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Olatec Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 9, 2025 | ||||
| Grant | Feb 20, 2024 | ||||
| Grant | Mar 10, 2023 | ||||
| Series A | Feb 23, 2023 |
Olatec Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advection Growth Capital | Series A |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Cure Parkinson's | Grant |
| Van Andel Institute | Grant |
| Sanders Morris Harris | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 2, 2025
Andy Cunningham joins the Board of Directors.
- Jan 28, 2025
Marc Y. Donath joins the Clinical Advisory Board.
Olatec Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Olatec Therapeutics's valuation, stock price, and market status.